131 related articles for article (PubMed ID: 7047153)
1. A case report of pseudohypoparathyroidism (Drezner's type I) associated with probable Bartter's syndrome.
Iba K; Morii H; Wada M; Yasumoto R; Kishimoto T; Mitsuhashi T; Hojo K; Okahara T
Endocrinol Jpn; 1981 Oct; 28(5):595-604. PubMed ID: 7047153
[TBL] [Abstract][Full Text] [Related]
2. [A case of pseudohypoparathyroidism (PHP) type II associated with Bartter's syndrome--restoration of phosphaturic response to parathyroid hormone (PTH) by treatment for hypopotassemia].
Bando Y; Miyakoshi H; Nagaoka T; Ohsawa K; Kobayashi K
Nihon Naibunpi Gakkai Zasshi; 1992 Jul; 68(7):676-87. PubMed ID: 1516722
[TBL] [Abstract][Full Text] [Related]
3. [Tetany as a sole manifestation in a patient with Bartter's syndrome and a successful treatment with indomethacin].
Fujihara K; Miyoshi T; Yamaguchi Y; Araki T; Tanaka K
Rinsho Shinkeigaku; 1990 May; 30(5):529-32. PubMed ID: 2401113
[TBL] [Abstract][Full Text] [Related]
4. Aldosterone and other mineralocorticoids in Bartter's syndrome.
Saruta T; Fujimaki M; Senba S; Saito I; Konishi K
J Lab Clin Med; 1984 Jun; 103(6):848-53. PubMed ID: 6373989
[TBL] [Abstract][Full Text] [Related]
5. Hypokalemia and prostaglandin overproduction in Bartter's syndrome.
Senba S; Konishi K; Saruta T; Ozawa Y; Kato E; Amagasaki Y; Nakata I
Nephron; 1984; 37(4):257-63. PubMed ID: 6379486
[TBL] [Abstract][Full Text] [Related]
6. [A case with Bartter's syndrome associated with type II hyperlipidemia, increased fluidity of plasma VLDL and abnormal configuration of peripheral erythrocytes (author's transl)].
Imai T; Makino K; Takeda N; Nakamura S; Endo Y; Okuyama M; Miura K; Iida H; Kawade M
Nihon Naibunpi Gakkai Zasshi; 1982 Feb; 58(2):131-47. PubMed ID: 7044842
[TBL] [Abstract][Full Text] [Related]
7. [A case report of Bartter's syndrome associated with possible pseudohypoparathyroidism type II].
Shigeta H; Tasaki N; Kitazumi S; Kitagawa Y; Kanatsuna T; Kondo M
Nihon Naika Gakkai Zasshi; 1987 Apr; 76(4):549-52. PubMed ID: 3611913
[No Abstract] [Full Text] [Related]
8. Effect of indomethacin in a patient with Bartter's syndrome: evidence against a primary role of prostaglandin in this disorder.
Etzioni A; Chaimovitz C; Levi Y; Benderli A; Better OS
Pediatr Res; 1980 Dec; 14(12):1395-7. PubMed ID: 7010289
[TBL] [Abstract][Full Text] [Related]
9. Effect of indomethacin upon the renin--angiotensin system in patients with Bartter's syndrome.
Vierhapper H; Waldhäusl W
Eur J Clin Invest; 1980 Apr; 10(2 Pt 1):119-24. PubMed ID: 6780358
[TBL] [Abstract][Full Text] [Related]
10. The effect of amiloride on the renin-aldosterone system in primary hyperaldosteronism and Bartter's syndrome.
Griffing GT; Aurecchia SA; Sindler BH; Melby JC
J Clin Pharmacol; 1982; 22(11-12):505-12. PubMed ID: 6761369
[TBL] [Abstract][Full Text] [Related]
11. Effect of Sar1-ala8-angiotensin II on blood pressure and renin in Bartter's syndrome, before and after treatment with prostaglandin synthetase inhibitors.
Rudin A; Aurell M; Hansson L; Westberg G
Scand J Clin Lab Invest; 1979 Oct; 39(6):543-50. PubMed ID: 119300
[TBL] [Abstract][Full Text] [Related]
12. Blood pressure fall by angiotensin II antagonist in patients with Bartter's syndrome.
Kono T; Oseko F; Shimbo S; Nanno M; Ikeda F
J Clin Endocrinol Metab; 1976 Sep; 43(3):602-5. PubMed ID: 956346
[TBL] [Abstract][Full Text] [Related]
13. [Plasma-aldosterone and renin activity in Bartter's syndrome (author's transl)].
Rössler R
Dtsch Med Wochenschr; 1975 Nov; 100(47):2443-8. PubMed ID: 171132
[TBL] [Abstract][Full Text] [Related]
14. Reversal of altered vascular responsiveness in Bartter's syndrome by indomethacin treatment.
Shimoyama R
J Clin Endocrinol Metab; 1980 Oct; 51(4):908-11. PubMed ID: 6999001
[TBL] [Abstract][Full Text] [Related]
15. Bartter's syndrome associated with indirect hyperbilirubinemia: a possible clinical variety.
Cugini P; Sasaki H; Kawasaki T; Di Simone S; Di Palma L; Battisti P; Uezono K
Endocrinol Jpn; 1990 Feb; 37(1):159-64. PubMed ID: 2200658
[TBL] [Abstract][Full Text] [Related]
16. [Development of tetany in siblings suffered from Bartter's syndrome].
Suitsu N; Kita S; Okamoto S; Kimura S; Shiozaki Y
No To Shinkei; 1984 Aug; 36(8):749-54. PubMed ID: 6498022
[TBL] [Abstract][Full Text] [Related]
17. Bartter's syndrome: effect of indomethacin on prostaglandins, urinary kallikrein, renin-angiotensin-aldosterone system, and the response to angiotensin II antagonist.
Sasaki H; Kawasaki T; Okumura M; Asano T; Abe K; Arakawa K
Endocrinol Jpn; 1980 Aug; 27(4):417-29. PubMed ID: 7007031
[No Abstract] [Full Text] [Related]
18. Responses to antiotensin II antagonist before and after treatment with indomethacin in Bartter's syndrome.
Sasaki H; Okumura M; Asano T; Arakawa K; Kawasaki T
Br Med J; 1977 Oct; 2(6093):995-6. PubMed ID: 922403
[No Abstract] [Full Text] [Related]
19. Bartter's syndrome. New insights into pathogenesis and treatment.
Solomon RJ; Brown RS
Am J Med; 1975 Oct; 59(4):575-83. PubMed ID: 1166859
[TBL] [Abstract][Full Text] [Related]
20. [Increased renal prostaglandin E2 secretion in Bartter's syndrome].
Schwarz HA; Weidmann P; Messerli FH; Zia PK; Flammer J; Reubi RC
Schweiz Med Wochenschr; 1977 Dec; 107(49):1870-2. PubMed ID: 929154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
